应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LITS Lite Strategy Inc.
休市中 01-09 16:00:00 EST
1.47
-0.02
-1.34%
盘后
1.44
-0.03
-2.04%
18:48 EST
最高
1.50
最低
1.43
成交量
31.29万
今开
1.48
昨收
1.49
日振幅
4.70%
总市值
5,407万
流通市值
4,410万
总股本
3,679万
成交额
45.77万
换手率
1.04%
流通股本
3,000万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营
投资观察 · 2025-11-20
Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营
Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作
美股速递 · 2025-11-17
Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作
美SEC开始对加密财库公司下手,DAT 叙事还继续吗?
深潮TechFlow · 2025-09-28
美SEC开始对加密财库公司下手,DAT 叙事还继续吗?
MEI Pharma公司纳斯达克股票代码将于2025年9月11日开盘时变更
美股速递 · 2025-09-10
MEI Pharma公司纳斯达克股票代码将于2025年9月11日开盘时变更
加载更多
公司概况
公司名称:
Lite Strategy Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lite Strategy, Inc.是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。
发行价格:
--
{"stockData":{"symbol":"LITS","market":"US","secType":"STK","nameCN":"Lite Strategy Inc.","latestPrice":1.47,"timestamp":1767992400000,"preClose":1.49,"halted":0,"volume":312863,"hourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.47,"latestTime":"18:48 EST","volume":4522,"amount":6512.0092,"timestamp":1768002502836},"delay":0,"floatShares":30000200,"shares":36785400,"eps":-1.31,"marketStatus":"休市中","change":-0.02,"latestTime":"01-09 16:00:00 EST","open":1.48,"high":1.5,"low":1.43,"amount":457658.468018,"amplitude":0.04698,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.31,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"listingDate":1071723600000,"exchange":"NASDAQ","adjPreClose":1.49,"preHourTrading":{"tag":"盘前","latestPrice":1.5048,"preClose":1.49,"latestTime":"09:09 EST","volume":3057,"amount":4594.260139,"timestamp":1767967778908},"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.47,"latestTime":"18:48 EST","volume":4522,"amount":6512.0092,"timestamp":1768002502836},"volumeRatio":0.5542520894136054,"impliedVol":1.3498,"impliedVolPercentile":0.3373},"requestUrl":"/m/hq/s/LITS","defaultTab":"news","newsList":[{"id":"1189532616","title":"Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1189532616","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189532616?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:58","pubTimestamp":1763575105,"startTime":"0","endTime":"0","summary":"Lite Strategy Inc :: *Lite Strategy公布2026财年第一季度财报,强调成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LITS"],"gpt_icon":0},{"id":"1156188236","title":"Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作","url":"https://stock-news.laohu8.com/highlight/detail?id=1156188236","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156188236?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:01","pubTimestamp":1763388071,"startTime":"0","endTime":"0","summary":"Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LITS"],"gpt_icon":0},{"id":"1131042676","title":"美SEC开始对加密财库公司下手,DAT 叙事还继续吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=1131042676","media":"深潮TechFlow","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131042676?lang=zh_cn&edition=full","pubTime":"2025-09-28 10:02","pubTimestamp":1759024941,"startTime":"0","endTime":"0","summary":"9 月 24 日,美国证券交易委员会与金融业监管局联合宣布,将对 200 余家曾宣布加密财库计划的上市公司展开调查,理由是这些公司在发布相关消息前夕普遍出现了「异常股价波动」。在财库策略公司语境下,NAV 则指的是其所持有的数字资产价值。公司并未提交重大更新,也未公开新闻稿,其发言人则拒绝对此置评。Arthur Hayes 判断,本轮周期会出现类似 FTX 暴雷的大型 DAT 事故。届时,这些公司会翻车,其股票或债券可能出现巨幅折价,造成市场大幅动荡。","market":"us","thumbnail":"https://static.tigerbbs.com/414360f2ef7b5c785cb936b4a9b53a44","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/414360f2ef7b5c785cb936b4a9b53a44"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3150824a1f2ef6b4c28c3f89c2312cb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.techflowpost.com/article/detail_28367.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"美SEC开始对加密财库公司下手,DAT 叙事还继续吗?","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1592805329705","symbols":["ETH","ETHV","MARA","BTCM","IBIT","ARKB","HODL","CLSK","FBTC","BRRR","DEFI","MSTR","BTCW","BTCO","EBON","GBTC","FETH","LITS","BTBT","BITO","QETH","COIN","SBET","BTM","ETHA","CAN","BITB","ETHW","RIOT","EZBC","CETH","NCTY","SOS","EZET","ETHE"],"gpt_icon":1},{"id":"1133041017","title":"MEI Pharma公司纳斯达克股票代码将于2025年9月11日开盘时变更","url":"https://stock-news.laohu8.com/highlight/detail?id=1133041017","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133041017?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:03","pubTimestamp":1757509401,"startTime":"0","endTime":"0","summary":"MEI Pharma公司宣布,其在纳斯达克的股票交易代码将于2025年9月11日市场开盘时正式变更生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LITS","MEIP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://litestrategy.com","stockEarnings":[{"period":"1week","weight":-0.0455},{"period":"1month","weight":-0.2011},{"period":"3month","weight":-0.4049},{"period":"6month","weight":-0.4535},{"period":"1year","weight":-0.4535},{"period":"ytd","weight":0.1136}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lite Strategy, Inc.是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.478261,"avgChangeRate":0.063883},{"month":2,"riseRate":0.409091,"avgChangeRate":-0.005853},{"month":3,"riseRate":0.409091,"avgChangeRate":-0.074385},{"month":4,"riseRate":0.545455,"avgChangeRate":0.020025},{"month":5,"riseRate":0.454545,"avgChangeRate":0.039254},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.082941},{"month":7,"riseRate":0.363636,"avgChangeRate":0.076909},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.010903},{"month":9,"riseRate":0.52381,"avgChangeRate":0.049595},{"month":10,"riseRate":0.380952,"avgChangeRate":-0.06395},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.039907},{"month":12,"riseRate":0.227273,"avgChangeRate":0.003146}],"exchange":"NASDAQ","name":"Lite Strategy Inc.","nameEN":"Lite Strategy Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lite Strategy Inc.,LITS,Lite Strategy Inc.股票,Lite Strategy Inc.股票老虎,Lite Strategy Inc.股票老虎国际,Lite Strategy Inc.行情,Lite Strategy Inc.股票行情,Lite Strategy Inc.股价,Lite Strategy Inc.股市,Lite Strategy Inc.股票价格,Lite Strategy Inc.股票交易,Lite Strategy Inc.股票购买,Lite Strategy Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}